Reuters logo
5 months ago
BRIEF-Keryx says FDA accepts application to expand use of Auryxia
March 8, 2017 / 1:26 PM / 5 months ago

BRIEF-Keryx says FDA accepts application to expand use of Auryxia

March 8 (Reuters) - Keryx Biopharmaceuticals Inc

* Keryx biopharmaceuticals announces u.s. Fda filing acceptance of supplemental new drug application for auryxia® (ferric citrate) tablets

* Keryx biopharmaceuticals announces u.s. Fda filing acceptance of supplemental new drug application for auryxia® (ferric citrate) tablets

* Keryx biopharmaceuticals inc- prescription drug user fee act (pdufa) target action date for completion of fda's review is november 6, 2017

* Keryx biopharmaceuticals inc- ferric citrate was generally well tolerated and adverse events were consistent with its known safety profile Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below